Temperature-Sensitive Tech: Cold Chain's Continuous Development
Temperature-Sensitive Tech: Cold Chain's Continuous Development
Inside Sanofi’s Shift Toward a Data-Driven Supply Chain Model
PC: You recently delivered a keynote presentation surrounding “How to Integrate E2E and Deliver ‘Miracles of Science’ to your Patients.” Could you provide a brief synopsis of what your session entailed? Beadle: Sanofi is undergoing a major transformation with the…
How the Rise of Personalized Medicine Impacts Life Sciences’ Logistics
Key Takeaways Personalized medicine demands precision logistics, with strict temperature control, real-time tracking, and regulatory compliance essential to ensure safe and timely delivery of patient-specific therapies. Gaps in last-mile delivery and third-party training pose serious risks, especially when handling temperature-sensitive,…
Balancing Benefits, Risks, and Public Perception with HPV Vaccinations; Pfizer-Backed CellCentric Secures $120M for Further Myeloma Trials
HPV Vaccine: Balancing Benefits, Risks, and Public Perception Despite ongoing lawsuits and public concerns about serious adverse events, current evidence supports the safety and effectiveness of the human papillomavirus vaccine in preventing a wide range of cancers, underscoring the need…
A Balancing Act
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in pharmaceutical R&D reveals a continued upward trend, with a projected…
Noom to Sell Microdoses of Wegovy
Image Credit: Adobe Stock Images/PeterHansen.com Key Takeaways Noom is now offering its own compounded version of semaglutide—an active ingredient in Wegovy and Ozempic—through its telehealth marketplace. The FDA has ended the semaglutide shortage and set a May 22 deadline for…
How Digitization Drives End-to-End Supply Chain Success
PC: How would you define successful E2E, and what specific processes are necessary in order to achieve this? Beadle: The first thing I’d highlight—and I mentioned this in the keynote—is that we are a company of scale and history. It’s…
The GLP-1 Effect
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in pharmaceutical R&D reveals a continued upward trend, with a projected…
HHS Policy Shift Could Boost Role of Patient Advocates in Clinical Trials
PC: How do you see the potential impact of HHS’s proposed policy change on patient advocacy efforts, particularly for rare and serious diseases? Leuchter: If I step back and think about how critical it is to receive input, feedback, and…
The Role of AI in Solving Clinical Trial Diversity and Access Challenges; FDA Advisors Unanimously Snub Pfizer’s Talzenna in Broader Prostate Cancer Population
The Role of AI in Solving Clinical Trial Diversity and Access Challenges In an interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, explained how AI can help address clinical trial diversity and access challenges by reducing…
Keeping Drug Supplies Available Means Pharmaceutical Organizations Must Move in Real-Time
Credit: Production Perig | stock.adobe.com Key Takeaways Embrace Real-Time Data for Proactive Supply Chain Management. Advanced manufacturing and real-time analytics help pharmaceutical companies predict and prevent drug shortages. Just like in retail, real-time demand tracking and inventory optimization ensure essential…
Bridging Innovation and Trust with Artificial Intelligence; AstraZeneca Partners with Aptar on Kidney Disease-Detecting AI
Bridging Innovation and Trust with Artificial Intelligence In a recent interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, discussed how AI is transforming clinical trials by reducing costs, accelerating timelines, and enhancing patient inclusion—while emphasizing the…
An Exploration of Compounding Practices
Main Takeaways 503B outsourcing facilities must comply with various FDA regulations, including current good manufacturing practices (cGMP), registration, labeling, and adverse-event reporting requirements, which distinguish them from 503A pharmacies and enable them to mass-produce and distribute compounded drugs for office…
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways Placebo-controlled trials now required for low-risk groups: FDA will require placebo-controlled trials for COVID-19 vaccines in low-risk populations before granting full approval—adding complexity to trial design, ethics reviews, and recruitment. New focus…
The Road to Simpler and Better Clinical Trials; FDA Outlines Stricter Covid Vaccine Booster Standards for Healthy People
Less is More in Clinical Data: The Road to Simpler and Better Trials In an article for Applied Clinical Trials, Drew Garty, chief technology officer, Veeva, emphasizes that simplifying clinical trial data management through pragmatic strategies—like endpoint-driven design, risk-based approaches,…
How the Loss of Subsidized Drug Coverage Could Impact Mortality
Image Credit: Adobe Stock Images/Weerasak.com The Low-Income Subsidy, or “Extra Help,” significantly reduces prescription drug costs for 14 million Medicare beneficiaries with limited income and resources. The Inflation Reduction Act eliminated the partial LIS program, making full benefits available to…
Decreasing Clinical Development Timelines
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in pharmaceutical R&D reveals a continued upward trend, with a projected…
Invensify, Go2 Delivery Collaborate on Temperature-Controlled Courier Service
Image Credit: Adobe Stock Images/GorodenKoff.com Invensify and GO2 Delivery’s partnership significantly reduces cold chain packaging costs—by up to 50%—while ensuring regulatory compliance for temperature-sensitive medications. The collaboration promotes sustainable healthcare logistics through real-time tracking and fully carbon-neutral same-day delivery operations….
A Strategic Imperative for Biopharma Commercial Success; Advocate for Change to Address Pharmacy Burnout
Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success Biopharma companies must adopt integrated strategies that engage both payers and health systems—each now powerful, parallel decision-makers—to overcome hidden barriers like “shadow formularies” and ensure successful therapeutic adoption…
White House Unveils Pharma Most-Favored-Nation Executive Order; FDA, CDC Call for Pause of Chikungunya Shot Rollout in Older Adults
White House Unveils Pharma Most-Favored-Nation Executive Order Pharmaceutical Executive reported that President Trump issued an executive order titled Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, aiming to lower US drug prices by requiring pharmaceutical companies to match or beat…
UnitedHealth Group CEO Departs
Image Credit: Adobe Stock Images/LucianoLuppa.com 1. Leadership shakeup amid crises: UnitedHealth Group CEO Andrew Witty has abruptly stepped down, citing personal reasons. His departure follows a year of major turmoil for the company, including a DOJ investigation, a massive cyberattack…
Themes Among Rare Disease Repurposing Efforts
Image Credit: Adobe Stock Images/Suriyo.com 1. Five-step repurposing process: The study outlined a five-stage process: enabling, identifying, validating, testing, and implementing repurposed drugs. 2. RDNPs drive success: Nonprofit involvement, especially in patient recruitment, was linked to successful repurposing outcomes, including…
A Closer Look at NIH Grant Terminations; Simulated Pre-Launch Market Evaluation in the Modern Pharmaceutical Industry
A Closer Look at NIH Grant Terminations In an interview with Applied Clinical Trials, Harvard Medical School researcher Michael Liu discussed a recent study analyzing NIH grant terminations, revealing that 20% of the cuts affected early career training grants—critical to…
Limiting the Use of Spread Pricing
Pharmaceutical Commerce: What specific pricing practice by pharmacy benefit managers (PBMs) does the Protecting Pharmacies in Medicaid Act aim to address? Anne Cassity: The Protecting Pharmacies in Medicaid Act really aims at getting rid of spread pricing and the Medicaid…
How to Manage Rising Drug Development Costs
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in pharmaceutical R&D reveals a continued upward trend, with a projected…
Inside the Daily Workflow of Sanofi’s Global Supply Chain Head
PC: As the head of global supply chain, what does your day-to-day workflow typically consist of? Beadle: Our primary responsibility is getting products to patients—that’s at the heart of what we do. Every day, I focus on identifying potential challenges…
Five Questions on Trump’s Plan to Lower US Drug Prices; Roche Reports Final Overall Survival Outcomes from Breast Cancer Treatment Trial
Five questions on Trump’s plan to lower US drug prices President Trump’s new plan to lower US drug prices by tying them to the lowest prices paid in other countries aims to fulfill campaign promises and pressure the pharmaceutical industry,…
The Positive Momentum Behind Pharma Innovation
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in pharmaceutical R&D reveals a continued upward trend, with a projected…
Bluebird Bio Warns of Potential Bankruptcy as Buyout Faces Another Delay; Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
Bluebird bio warns of potential bankruptcy as buyout faces another delay Bluebird bio has warned of possible bankruptcy after buyers Carlyle and SK Capital extended their acquisition deadline yet again due to insufficient shareholder participation, as only about 26% of…
White House Introduces Most Favored Nation EO
Image Credit: Adobe Stock Images/MAlfanSetyawan.com It’s no secret that for years, critics have commented about the prices for medication in the UnitedStates being exorbitantly high. In response to this issue, President Donald Trump yesterday unveiled a new executive order (EO)—Delivering…
Serialization System SOPs
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus…
Piramal Pharma to Invest $90 Million in US Site Expansions
Rendering of the new Lexington sterile fill-finish facility. Image Credit: Piramal Pharma Ltd. Piramal Pharma Limited, a global pharmaceuticals and wellness company, will be investing $90 million toward growing two of the company’s plants located in the United States: Lexington,…
Handling Pharma Supply Chain Disruptions
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus…
Key Takeaways From the 2025 HDA Distribution Management Conference
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus…
Teva Plots Thousands of Job Cuts as Restructuring Drive Enters ‘Acceleration’ Phase, Takeda to Invest $30B Into US Operations
Teva plots thousands of job cuts as restructuring drive enters ‘acceleration’ phase Teva is set to cut around 2,400 jobs, about 8% of its workforce, as part of its “Acceleration Phase” in the ongoing restructuring plan aimed at saving $700…
Hybrid Hub Models for the Patient Journey
In this video, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, discusses the balance between technology and human interaction to support patients and programs. Patient support program strategies must be tailored to the…
Is the Industry Ready for the DSCSA?
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of topics within the pharmaceutical supply chain, with a special focus…
Measuring What Matters
The latest wave of artificial intelligence (AI), digital health, and direct-to-patient (DTP) models have the potential to drive significant innovation, transform patient experiences, and redefine business and operating models across life science companies. Estimates show that AI alone could drive…
J&J Survey Finds Pace of Oncology Innovation is Overwhelming Physicians, Biotech is Guessing How Vinay Prasad Might Change the FDA
J&J survey finds pace of oncology innovation is overwhelming physicians A recent J&J survey reveals that oncologists are overwhelmed by the rapid pace of oncology innovation, highlighting the need for additional support and continuing medical education to help them keep…
Antares Vision Group, Siempharma Strike Up Pharma Labeling Equipment Collaboration
The ETF-300. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including the life sciences, is growing its solutions portfolio to now include precision labeling equipment. The company is collaborating with Siempharma, a…
GLP-1 Drugs Reshape Reimbursement and Coverage Models
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted the rapid growth of specialty pharmaceuticals—now comprising over half of the…
SK Pharmateco Debuts New cGMP Plasmid Suite
Image Credit: Adobe Stock Images/N0m3rcy.com SK pharmteco, a contract development and manufacturing organization (CDMO), has opened a new, 300,000 square-foot current good manufacturing practice (CGMP) plasmid suite at its plant in King of Prussia, PA.1 The project demonstrates the company’s…
Tracking Long-Term Outcomes Key to Advanced Therapy Value
In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state of the market, the anticipated growth of the pipeline, and the…
Digital Health and Biosimilars Shape the Future of Pharmacy
At this year’s Asembia Summit, Pharmaceutical Commerce sat down with Blake Powers, CEO of Medigi, to discuss the company’s role in bridging innovation and patient access in the life sciences space. Powers shared his insights on the evolving landscape of commercialization, the…
Designing Smarter Interventions with Community Insights
As the healthcare industry sharpens its focus on patient-centered care, addressing social determinants of health, health equity, and literacy has become more critical than ever—particularly for individuals with chronic and rare conditions. During the “Speaking Health and Human: Bridging the Gap…
Why AI Could Be the Key to Solving Access Challenges in Healthcare
In an interview with Pharmaceutical Commerce, Chip Parkinson, the new CEO of Gift Health, shared his perspective on stepping into the role and the evolving challenges and opportunities across the healthcare landscape. Drawing on a diverse background that spans manufacturers, payers,…
Trending Data & Response Plans in the Cleanroom Setting
Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM can implement industry-leading cleanroom solutions for your facility.
ABM’s Digital Solution for Good Manufacturing Practices
March 14th 2025 Article A regional hospital serving suburban Indianapolis, Hancock Regional Hospital faced a familiar challenge: disparate monitoring systems that taxed their staff and too many manual processes that drove inefficiencies. CEO Steve Long greenlit a solution: a consolidated…
Rare Disease Therapies Drive Shift in Drug Development Focus
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted the rapid growth of specialty pharmaceuticals—now comprising over half of…
The Medicare Part D Cap and Medicare Prescription Payment Plan
April 30, 2025 Amy Niles, chief mission officer, PAN Foundation, discusses the latest changes to the Medicare program that have the potential to improve patient access to care, along with the work needed to generate awareness about them.
Rethinking the Drug Distribution Process
Image Credit: Nicholas Saraceno The final day of education at Asembia’s AXS25 Summit kicked off with a multitude of early morning sessions, including one focused on “Beyond Limits: Rethinking Drug Distribution to Drive Patient-Centered Care.” Led by Mike Reff, RPh,…
Therapy Advancements Highlight Growing Cost and Access Concerns
In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state of the market, the anticipated growth of the pipeline, and…
Addressing Polypharmacy Challenges in Europe with Real World Evidence
Multimorbidity and associated polypharmacy, including use of potentially inappropriate medication (PIM), are an increasing challenge for European health systems. A lack of cross-national studies using standardized methodology and comparable study populations makes it difficult to determine the prevalence of polypharmacy…
What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes
The second day of Asembia’s AXS25 Summit featured a session that addressed a distinct set of challenges facing the pharmaceutical industry. Titled “Beyond the Headlines: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes,” the discussion highlighted…
The Cost of Care for Patients
Image Credit: Nicholas Saraceno The afternoon sessions here on day 3 of Asembia continued its impressive slate, with its various business seminars as proof. One of which was centered around “The Cost of Care for Patients: Navigating the Financial Assistance…
How Specialty Pharmacies Are Evolving to Support Rare Conditions
In an interview with Pharmaceutical Commerce, Will Pih, co-founder, Two Labs, shared insights from his recent panel discussion on “Economics and Specialty Pharmacy for Rare Diseases: Challenges and Opportunities.” The conversation explored the growing complexities of delivering care in the…
Understanding the Inflation Reduction Act
Image Credit: Nicholas Saraceno The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on “Navigating the IRA: What Have We Learned? What is on the Horizon?” The IRA—or Inflation Reduction Act—is…
How AI and Payer Collaboration Are Shaping Pharmacy’s Future
In an interview with Pharmaceutical Commerce, Chip Parkinson, the new CEO of Gift Health, shared his perspective on stepping into the role and the evolving challenges and opportunities across the healthcare landscape. Drawing on a diverse background that spans manufacturers,…
Bridging Health Gaps Through Equity and Education
As the healthcare industry sharpens its focus on patient-centered care, addressing social determinants of health, health equity, and literacy has become more critical than ever—particularly for individuals with chronic and rare conditions. During the “Speaking Health and Human: Bridging the…
The Role of Face-to-Face Connection in Pharma Commercialization
At this year’s Asembia Summit, Pharmaceutical Commerce sat down with Blake Powers, CEO of Medigi, to discuss the company’s role in bridging innovation and patient access in the life sciences space. Powers shared his insights on the evolving landscape of…
Why Distractions Are Detrimental to Business
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing and supply chain for its HIV therapy, EGRIFTA SV. The…
Analyzing Tariffs’ Effect on the Biopharmaceutical Supply Chain
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing and supply chain for its HIV therapy, EGRIFTA SV. The…
IATA CEIV Celebrates a Decade of Enhancing Air Cargo Efficiency
Image Credit: Adobe Stock Images/OMS.com The International Air Transport Association (IATA) is celebrating 10 years of its Center of Excellence for Independent Validators (CEIV) program, which evaluates a company’s the air cargo supply chain efforts when it comes to quality,…
The Future of Specialty Medicine
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing and supply chain for its HIV therapy, EGRIFTA SV. The…
Will Moving Drug Production to the United States Help or Hurt Patients?
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing and supply chain for its HIV therapy, EGRIFTA SV. The…
Fast-Tracking the Future
Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer, Thermo Fisher to Invest Addlitional $2 Billion In US To Boost Manufacturing
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer Roche expects to weather the financial impact of Trump-era tariffs due to its strategic US manufacturing shifts and global investments, though M&A activity may slow as…
PCI to Purchase Full Stake in Ajinomoto Althea
Image Credit: Business Wire PCI Pharma Services, a contract development and manufacturing organization (CDMO), will be purchasing a full stake in Ajinomoto Althea, Inc., a sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co., Inc., for an undisclosed amount.1 The…
Understanding True Meaning of Risk in Clinical Trial Operations, European Pharma Companies Push for Higher Drug Prices Amid US Tariff Threats
Understanding the True Meaning of Risk in Clinical Trial Operations In a recent interview with Applied Clinical Trials, Rob Jones of Pharmalex emphasized the need for TMF leaders to adopt a truly risk-based, quality-by-design mindset. This includes embracing innovations such…
Three Ways to Turn Sustainability Pledges Into Progress
PC: How can stakeholders ensure that sustainability takes precedence, even over other important business drivers? Ganguly: There are three key takeaways from the panel—and from observing how the sustainability movement has evolved. First, it’s important to share practical proof points….
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation, Trump Assessing Slashing US Drug Prices to International Levels
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation Regeneron and Roche are investing a combined $53 billion over the next decade to expand US manufacturing and R&D infrastructure—spanning biologics, gene therapy, AI-driven research,…
Driving Business Success Through Sustainability
PC: You just wrapped up a panel discussion on “Uniting on Sustainability: How can we drive collaboration and ground-breaking initiatives to ensure ESG is a top business priority?” With sustainability being such a priority nowadays, what were some the highlights…
FDA Moves to Block Biopharma Employees From Serving on Advisory Committees, FDA Cuts Outlined in Draft HHS Budget
FDA moves to block biopharma employees from serving on advisory committees The FDA has issued a new directive barring employees of FDA-regulated biopharma companies from serving on its advisory committees to reduce perceived industry influence and promote greater transparency, while…
Thermo Fisher Scientific Unveils Advanced Therapies Collaboration Center
Image Credit: Thermo Fisher Scientific Thermo Fisher Scientific has officially opened its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, CA.1 The plant is intended to speed up both the development and commercialization of cell therapies, in an effort to both…
Why Patient Empowerment is Key
In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key sessions: “Establishing and Transitioning to a Foundation” and “Empowering Patients to Take Control of Their Healthcare.” The first session focuses…
Pharma Companies Expected to Absorb Any Tariff Hit in Short Term, New Chronic Antigen Exposure Data, & more
Pharma companies expected to absorb any tariff hit in short term While US tariffs on pharmaceuticals may eventually raise drug prices, especially for generics, experts say brand-name costs will likely be absorbed by manufacturers in the short term—impacting profits, research,…
FDA Grants Interchangeability Designation to Celltrion’s Humira Biosimilar Yuflyma
Image Credit: Adobe Stock Images/Monchisa The FDA has granted interchangeability designation to Celltrion’s Yuflyma (adalimumab-aaty), a high-concentration (100 mg/mL), citrate-free biosimilar of Humira (adalimumab), across multiple inflammatory indications. The designation allows pharmacists, subject to state laws, to substitute Yuflyma for…
Leading with Purpose
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his…
The Quest to Deliver Reliability
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his…
Lessons from Life Sciences and Beyond
For a child with autism spectrum disorder (ASD), effective care coordination across the required medical, physical rehabilitation, counseling, occupational, and speech providers is challenging, especially when the aim is to provide individualized care—at scale across many patients. Genial Care, a…
Bringing Biotech Innovation Across Borders, Role of Collaboration in Advancing Rare Disease Research
Bringing Biotech Innovation Across Borders A feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets. The Role of Collaboration in Advancing Rare Disease Research In…
The Real Work Behind the Annual Program
PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader global LogiPharma portfolio, my team now focuses solely on this event. These days, it’s a year-round project—365 days. Once this…
Meribel Pharma Solutions Joins the CDMO Marketplace
Image Credit: Adobe Stock Images/Metamorworks.com There is a new contract development and manufacturing organization (CDMO) in the marketplace. With the ultimate goal of boosting patient health through its manufacturing services, Meribel Pharma Solutions has officially launched, bringing with it a European network…
Pharma Leaders Prioritize Artificial Intelligence and Sustainability
PC: When comparing this year to previous years, how would you say the main discussion points of LogiPharma have evolved? Robinson: I’m sure I’m not the only one saying this, but the big one is AI. The pace of growth…
April 2025 Interactive Digital Edition
Pharmaceutical Commerce: April 2025 Interactive Digital Edition The Cold Chain’s Evolution Tariffs Galore: Where Do We Stand? Conference Connect: Progressing Patient Assistance The Hot Market for Cold Chain Services Reducing Risk in the Pharmaceutical Cold Chain An AI-Pharma Transport Collaboration…
LogiPharma to Move to Vienna for Sustainability and Focused Sessions
PC: What was the thought process behind moving LogiPharma to Vienna in 2026? Robinson: First and foremost, it’s about the capabilities of the venue. Lyon has been wonderful and has served us well, but we’re looking to expand the agenda…
The Role of CDMOs in the Pharma Cold Chain Machine
The pharmaceutical cold chain sector plays a crucial role in ensuring the safe and effective delivery of temperature-sensitive medications, including advanced therapy medicinal products (ATMPs). For the last decade, it’s been crucial for contract development and manufacturing organizations (CDMOs) to…
An AI-Pharma Transport Collaboration
Logistics play a very important role in the pharmaceutical industry, as the activities involved are highly sensitive to time and quality control. It involves delivering drugs to the right place, at the right time, in a safe and secure manner,…
The Evolving Role of Operations in Advancing Therapeutic Delivery
PC: What general advice do you have for other pharma supply chain stakeholders when it comes to delivering change that boosts growth, augments pipelines, and increases productivity? Lang: First of all, I think there needs to be alignment and a…
Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more
Long-Term Sustainability for Diverse Trial Initiatives LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses how Takeda will ensure that diversity and inclusion remain a priority in its clinical trials moving forward. Payers Consider Policy Options for…
Hubs East 2025: Building a Thriving Culture
In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how in response to rising healthcare costs, employers have turned to high-deductible health plans and higher out-of-pocket (OOP) expenses, causing patients…
Harnessing Technology to Advance Operations and Patient Impact
PC: How can technology play a role in implementing these changes, and what challenges can it help overcome? Lang: Technology has fundamentally changed our lives outside of work—and it has also brought significant transformation and opportunity within the workplace. In…
What Your Data Can Tell You About Illicit Trade Risk
One of the objections I sometimes hear when discussing counterfeiting and diversion challenges with pharmaceutical manufacturers, particularly smaller ones, is that they just don’t know enough about the problem. They may suspect they have a problem and/or they may have…
Four Ways to Increase Speed to Therapy
Let’s start with an alarming pair of statistics. First, 40% of specialty product prescriptions actually get filled, and second, when a patient’s copay or out-of-pocket cost exceeds $250, the abandonment rate is nearly 70%. Pharmaceutical manufacturers are focused on making…
Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit
Welcome to the third installment of my “Popping the Gross-to-Net Bubble” series. In my previous column, I explored actionable steps pharmaceutical manufacturers can take to address gross-to-net (GTN) challenges for products reimbursed under the medical benefit. This time, I focus…
Healthcare Scorecard from Patients with Chronic Illness
Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from accessing essential treatments and medications. That’s according to the PAN Foundation’s Center for Patient Research State of Patient Access Report initiative. The latest…
Reevaluating One’s CGT Value Chain
Image Credit: Nicholas Saraceno LogiPharma Europe continued its star-studded lineup featuring Big Pharma, with a morning keynote case study on “Rethinking Your C> Value Chain: How to Ensure Readiness for Evolving Specialized Therapy Requirements.” Led by Graham White, BMS’ executive…
US Drug Price Negotiations and Transparency
When I was penning my latest column for Pharma Commerce, I felt that various recent developments were worth noting, considering the impact they could have on the US prescription drug market. They include the drug industry’s push to make Inflation…
GenAI’s Real Impact on Life Sciences Manufacturing
The COVID-19 pandemic highlighted our supply chains’ weaknesses like never before. A sudden surge in demand and limited production capabilities led to critical shortages of medical supplies, pharmaceuticals, and even basic consumer goods. For life sciences, this disruption wasn’t just…
Maintaining R&D Investments in the IRA Era
Developing effective lifesaving drugs requires significant research and development (R&D) investments. New medications cost an average of $2.3 billion to develop,1 largely funded by existing drug sales. At the same time, pharmaceutical companies are under increasing pressure from the government…
How Various Programs Affect Patient Care and Health Equity
In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how in response to rising healthcare costs, employers have turned to high-deductible health plans and higher out-of-pocket (OOP) expenses, causing patients…
Boehringer Ingelheim Opens $31.5 Million Oncology Antibody-Drug Conjugate Facility in Switzerland
Image Credit: Adobe Stock Images/MichaelVi Boehringer Ingelheim announced the official opening of a new antibody-drug conjugate (ADC) research and development facility in Basel, Switzerland, through its wholly owned subsidiary, NBE Therapeutics. According to the company, the $31.5 million facility will…
Balancing Cost-Efficiency with Domestic Manufacturing Need, Making M3P Work for Your Pharmacy & more
Balancing Cost-Efficiency with the Need for Domestic Manufacturing Marcel Botha, CEO of 10XBeta, discusses finding a balance between the need for cost-efficiency and the need to build domestic manufacturing capacity for essential medical devices. Making M3P Work for Your Pharmacy:…
Analyzing the Theranos Appeals, Current CAR-T Therapy Trends in Managed Care & more
Analyzing the Theranos Appeals Matthew Yelovich, partner at Cleary Gottlieb, discusses the appeals of Elizabeth Holmes and Ramesh “Sunny” Balwani and the Ninth Circuit’s recent affirmation of their convictions. Current CAR-T Therapy Trends in Managed Care | AMCP Annual 2025…
Establishing and Transitioning to a Foundation
In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key sessions: “Establishing and Transitioning to a Foundation” and “Empowering Patients to Take Control of Their Healthcare.” The first session focuses…
The ‘Healthy Immigrant Effect’, Google Gemini, AI Commercialization in Pharma & more
Google Gemini, AI Commercialization in Pharma and More Google recently released an updated version of its AI LLM. Gemini 2.5 Pro boasts a variety of new features that could help integrate AI even more into various workflows. It is still…
Reasons Behind the Rising Popularity of DTC Online Prescription Services
In a video interview with Pharma Commerce, Colin Banas, MD, DrFirst’s chief medical officer, describes have many Americans face significant challenges in accessing GLP-1 drugs due to their high cost. Despite the growing popularity and usage of these medications, which…
Siemens Inks $5.1 Billion Deal for Dotmatics
Image Credit: Adobe Stock Images/Tun.com Siemens AG, a technology conglomerate, has acquired Dotmatics, an R&D scientific software company, from private equity firm Insight Partners for $5.1 billion.1 “By acquiring Dotmatics, we’re strategically strengthening our position in life sciences and creating…
The Growing Role of DTC Healthcare
In a video interview with Pharma Commerce, Colin Banas, MD, DrFirst’s chief medical officer, describes have many Americans face significant challenges in accessing GLP-1 drugs due to their high cost. Despite the growing popularity and usage of these medications, which…
Trump Issues New Reciprocal Tariffs
Image Credit: Adobe Stock Images/Bashirlrshad.com Yesterday afternoon, as reported by AP,1 US President Donald Trump announced that he will be enacting reciprocal tariffs on countries that are running trade surpluses with the United States—which is when the value of its…
Understanding Copay Accumulators, Maximizers, and Alternative Funding Programs
In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how in response to rising healthcare costs, employers have turned to high-deductible health plans and higher out-of-pocket (OOP) expenses, causing patients…
Hims & Hers Begins Selling Zepbound
Image Credit: Adobe Stock Images/Douglas.com A Reuters report1 noted that Hims & Hers began selling various Eli Lilly drugs on their platform—both branded forms of tirzepatide—including Zepbound, a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for weight loss,…
The Financial Barrier to GLP-1s
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, discusses the challenges that many Americans face regarding the affordability of GLP-1 drugs.
DHL Purchases Cryoport’s Specialty Courier
Oscar de Bok, CEO of DHL Supply Chain, and Jerrell Shelton, CEO of Cryoport. Image Credit: DHL Supply Chain DHL has purchased CRYOPDP, Cryoport’s specialty courier powered by clinical trials, biopharma, and cell and gene therapies.1 In that same breath,…
Embarking on the CAR-T Journey
Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.
Balancing Technology, Personalization, and Human Connection in Patient Support
PC: What are some of the biggest challenges in ensuring continued medication adherence for specialty patients? Butler: While technology and high-touch support are important, personalization is equally critical. Emotions fluctuate daily, and medication regimens, as well as chronic conditions, evolve…
How Engagement Strategies Are Evolving in Specialty Pharmacy
PC: How is the role of patient engagement evolving in specialty pharmacy? Butler: It’s becoming increasingly critical to evolve patient support in specialty pharmacy, as patients now expect more personalized care. With the rapid advancement of technology, they also anticipate…
Singota Solutions Opens New Plant in Balerna, Switzerland
Image Credit: Singota Solutions Following the launch of last year’s site in Rovello Porro, Italy,1 Singota Solutions, a contract development and manufacturing organization (CDMO), has opened a new 100,000 square-foot plant in Balerna, Switzerland.2 Balerna is located near the Swiss-Italian…
The Role of Emotional Support in Improving Patient Adherence
PC: What are some common barriers patients face when starting specialty medications, and how can peer-to-patient outreach help? Butler: Our program is a peer-to-patient platform, which I believe is critical. It addresses emotional barriers such as fear, misinformation, mistrust, anxiety,…
LillyDirect Platform to Help Provide Alzeheimer’s Support
Image Credit: Adobe Stock Images/Orawan.com Eli Lilly and Company is growing its LillyDirect digital healthcare platform to offer independent in-person and telehealth support for people in the United States that are living with Alzheimer’s disease, many of whom may have not been…
Hubs East 2025: Navigating Specialty Medication Onboarding
PC: How does Pleio’s GoodStart program assist specialty pharmacies in improving patient engagement and adherence? Butler: Onboarding onto specialty medications is a complex and often overwhelming process for patients. That’s the core challenge Pleio addresses with our GoodStart program. We…
AstraZeneca Financially Commits $2.5B Toward New R&D Center
Image Credit: Adobe Stock Images/Pier.com Combined with research and manufacturing agreements, AstraZeneca is investing $2.5 billion into its sixth global strategic research & development (R&D) center in Beijing.1 The five-year financial commitment is part of a deal with the Beijing…
Futureproofing Pharma Supply Chains
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry. He highlights the complexity of supply chains in this sector,…
Examining Healthcare Spending Across US Counties
Image Credit: Adobe Stock Images/Gaming.com Although the United States spends an exorbitant amount on healthcare, amounts across the individual states vary. In fact, studies have so that there are some counties that spend more than five times as much per…
Hubs East 2025: The Patient Access Landscape
Image Credit: Nicholas Saraceno The final day of Informa’s Access USA conference arrived quickly, and I decided to attend a session along the Hubs East track focused on “The Changing Landscape of Patient Access—Accumulators, Maximizers & Alternative Funding.”1 Featuring Meredith…
The Unfinished Work of Healthcare Reform
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including nonprofit safety nets, third-party organizations, and manufacturer-sponsored free drug initiatives—have…
Spreading Awareness of Medicare Part D Reforms
Image Credit: Nicholas Saraceno Informa’s Access USA conference from Philadelphia continued with its first panel discussion of the conference. Amy Niles, chief mission officer of the PAN Foundation—a national charitable foundation and healthcare advocacy group—was joined by Bill Allen, a…
How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including nonprofit safety nets, third-party organizations, and manufacturer-sponsored free drug initiatives—have…
New Ways of Targeting Cancer, How Employers Can Support Employee Well-Being and Mental Health & more
New Ways of Targeting Cancer Company executives provide updates on cancer treatment pelareorep and other elements of the company’s pipeline. How Employers Can Support Employee Well-Being and Mental Health Trust remains a sensitive subject amongst employees as the shortage of…
The Biggest Bottlenecks for Patients, Age and Comorbidities Drive RSV Hospitalization Rates & more
The 2025 Medication Access Report: Biggest Bottlenecks for Patients Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, highlights gaps in data sharing and cross-functional collaboration as major bottlenecks that are causing delays, rework, and increased patient burden. Age…
The Ongoing Challenge for Nonprofit Patient Assistance Programs
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including nonprofit safety nets, third-party organizations, and manufacturer-sponsored free drug initiatives—have…
PAP 2025: Boosting Patient Empowerment
Image Credit: Nicholas Saraeno Day 2 of Informa’s Access USA track-based coverage carried on, with an afternoon session on the PAP track being run by Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, an independent entity from the…
PAP 2025: Understanding the Uninsured Landscape
Image Credit: Nicholas Saraceno Day 2 of Informa’s Access USA conference represented the start of its track-based sessions. In terms of the patient assistance & access program (PAP) focus of the conference, Aaron Winn, associate professor at the University of…
The Impact of Out-of-Pocket Costs on Patients with Rare Diseases
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including nonprofit safety nets, third-party organizations, and manufacturer-sponsored free drug initiatives—have…
How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including nonprofit safety nets, third-party organizations, and manufacturer-sponsored free drug initiatives—have…
Access USA 2025: Uncovering Patient Access Complexities
Image Credit: Nicholas Saraceno Informa’s Access USA Conference leveraged its KOL base with a roundtable on “Unravelling the Complexities of Patient Access and Affordability.”1 Featuring Ian Ocilka, ConnectiveRx’s chief strategy officer as moderator, he was accompanied by Nancy Bell, vice president…
This Year’s State of the Industry
Image Credit: Nicholas Saraceno Day 1 of Informa’s Access USA Conference from Philadelphia—featuring Patient Assistance & Access Programs (PAP) and Hub and Specialty Models East—was kicked off by Tommy Bramley, Cencora’s SVP of global consulting services. Titled “State of the…
How Pharma Leaders Can Secure Supply Chains
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry. He highlights the complexity of supply chains in this sector,…
The Impact of Automation on Costs and Variability
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in curing cancer and rare diseases. These therapies are safe and…
Building Adaptability in the Pharmaceutical Industry
It’s no secret that the pharmaceutical industry is facing a myriad of challenges and disruption, such as complex, costly, and lengthy new drug development; global regulatory hurdles; more start-ups entering the market every day, increasing competition; new technology and data…
Hancock Health Case Study: Pharmacy Temperature Monitoring
March 14th 2025 Article Transitioning from manual temperature logs and reactive power outage management to a comprehensive cloud-based monitoring solution, Discount Drug Mart has revolutionized its approach to pharmacy operations and compliance. Adopting Sonicu’s advanced system, this Ohio-based retail pharmacy…
Sonicu and Pharmacy Stars help hospital-based pharmacy with a powerful software integration
November 21st 2024 Article The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such…
How Sonicu supports remote clinics and pharmacists with a 24/7 cloud-based remote monitoring solution
March 14th 2025 Article A regional hospital serving suburban Indianapolis, Hancock Regional Hospital faced a familiar challenge: disparate monitoring systems that taxed their staff and too many manual processes that drove inefficiencies. CEO Steve Long greenlit a solution: a consolidated…
Pre-Launch Prep for Emerging Biopharmas, Using the Power of Three to Simplify the Business of Healthcare & more
Pre-Launch Prep for Emerging Biopharmas: Data First, Then the Rest Making early commercial data and analytics decisions for launch cen future-proof their data management. The Power of Three To Help Simplify the Business of Healthcare The healthcare industry faces unprecedented…
Breaking Down Regulatory Challenges in Cell Therapy Production
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in curing cancer and rare diseases. These therapies are safe and…
Cold Chain Technologies Inks Deal for Global Cold Chain Solutions
Image Credit: Adobe Stock Images/WatermillStudio.com Cold Chain Technologies (CCT), a US-based provider of thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, has acquired Global Cold Chain Solutions (GCCS), a provider of passive cold chain solutions based in…
Navigating Internal Constraints and Uncertainty
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry. He highlights the complexity of supply chains in this sector,…
Syngene Purchases First US Manufacturing Facility for $36.5M
In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, and manufacturing organization (CRDMO), acquired its first biologics site in the United States for $36.5 million.1 Equipped with multiple monoclonal antibody (mAbs) manufacturing lines,…
Overcoming Bottlenecks in Personalized Medicine Manufacturing
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in curing cancer and rare diseases. These therapies are safe and…
PharmaCord, Mercalis Merge in an Effort to Support the Patient Journey
Image Credit: Adobe Stock Images/Mrzproducer.com PharmaCord LLC, a provider of patient services for the biopharmaceutical industry, and Mercalis, a life sciences commercialization partner, are merging to create a “total solutions provider” for the biopharma sector that is expected to offer…
President Trump to Double Tariffs on Canadian Steel and Aluminum
Image Credit: Adobe Stock Images/Ketsara.com On Tuesday morning, as reported by AP,1 US President Trump announced that the original tax on steel and aluminum coming from Canada will double—increasing from 25% to 50%—due to the premier of Ontario, Doug Ford,…
Unlocking the Potential of Cell and Gene Therapies
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in curing cancer and rare diseases. These therapies are safe and…
The Case for Reshoring Manufacturing to the United States
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry. He highlights the complexity of supply chains in this sector,…
Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders
The pharmaceutical manufacturing sector is experiencing a profound transformation driven by technological advancements, regulatory shifts, and market dynamics. Industry leaders are facing both unprecedented challenges and opportunities, making it essential to adopt new strategies to stay competitive. Innovations in manufacturing…
Tariff Impact on Medication Availability/Accessibility for Telehealth Patients, Addressing the Gap in Type 1 Diabetes Care & more
Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry, highlighting that tariffs will initially affect…
Regulatory Agencies Role in Battle Against Misinformation, Developing Winning Supplemental Benefits Packages & more
The Role Regulatory Agencies Should Play in the Battle Against Misinformation In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, explores what kind of role regulatory agencies should play in the battle against misinformation. Developing Winning…
Shaping Trust Through Design, New Interest in Direct Contracting & more
Healthcare’s Visual Future: Shaping Trust Through Design The six key design trends of 2025 redefine how healthcare brands can inspire trust and build lasting connections with their audiences. Direct Contracting: Not New, But New Interest Direct contracting is not a…
Trump Delays Certain Tariffs on Canada and Mexico
Image Credit: Adobe Stock Images/MariusFaust.com A couple days following a tax that had gone into effect on various goods coming in from Canada and Mexico, President Trump has decided to postpone several of his previously announced1 25% tariffs on these…
Streamlining Prescription Processes
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming an increasingly prominent issue in the United States. Polypharmacy has…
Astellas, YASKAWA Partner to Form New Cell Therapy Manufacturing Joint Venture
Image Credit: Adobe Stock Images/PinkEyes.com Astellas Pharma and YASKAWA Electric Corporation have signed a definitive agreement that officially commences a joint venture that revolves around the design of a cell therapy product manufacturing platform using Maholo, a dual-armed, humanoid robot…
Overcoming Health Data Blockages in Polypharmacy
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming an increasingly prominent issue in the United States. Polypharmacy has…
Understanding the Legal Implications of Tariffs on the Pharma Supply Chain and Prescription Drug Pricing
PC: What are the legal implications of the latest tariffs—including the “reciprocal” variety—and what challenges do they present to the pharma supply chain? Lanton: Reciprocal tariffs could create significant disruptions in the supply chain and many commercial contracts. I don’t…
Novo Nordisk Launches DTP Delivery Service for Wegovy
Image Credit: Novo Nordisk Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) form of delivery that provides cash-paying patients with access to all dose strengths of Wegovy for $499 per month, at a lower…
How a Completely Open Generic Market Could Alter Rx Costs
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California (USC, describes how the 10% tax on Chinese goods…
Tariffs on Canada and Mexico Now Official
It’s official—Trump’s tariffs on Canada and Mexico have now taken effect. In what the US president says is being tied to the threat posed by illegal aliens and drugs, including fentanyl, a 25% tariff has been implemented on imports from…
The Connection Between Pharma Innovation and Health Policy Development
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California (USC, describes how the 10% tax on Chinese goods…
Keys to Advancing HCP Engagement
The landscape of healthcare provider (HCP) engagement has undergone a fundamental transformation. While traditional face-to-face interactions remain valuable, today’s HCPs interact across multiple channels throughout their day—from websites to social media platforms, professional forums, and digital portals. This evolution demands…
Delivering Personalized Experiences at Scale, Combat Counterfeit Medications & more
Delivering Personalized Experiences at Scale: A Fresh Look at Customer Centricity Customer centricity. An overused buzzword in the life sciences industry. Yet an important goal. In an era of eroding rep access, fragmented channels and growing complexity in treatment decisions, building…
Will Tariffs Affect Branded Drug Prices?
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California (USC, describes how the 10% tax on Chinese goods…
Selecting the Right 3PL
Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.
Trump Intends to Impose 25% Tariffs on Canada, Mexico Starting March 4
Image Credit: Adobe Stock Images/Natalia.com In early February, the news had originally broke that President Trump signed three executive orders that would enact tariffs on three key US trade partners: Canada, Mexico, and China.1 These taxes on imports, noted Trump…
Four Pivotal Trends Revolutionizing Market Access Strategies
As the pharmaceutical landscape evolves, ensuring market access should remain a top priority for industry stakeholders. As we look ahead to a year of expected advancements, several key trends will shape the landscape for manufacturers and key players. Here are…
Lilly to Build Four New US Manufacturing Facilities
Image Credit: Adobe Stock Images/StockMarketVisuals.com In an effort to increase its domestic medicine production across various therapeutic areas, Eli Lilly and Company will be constructing four new pharmaceutical manufacturing sites in the United States, representing financial commitments in the expansion space exceeding…
How Supply Chain Issues Lead to Drug Price Surges and Quality Concerns
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California (USC, describes how the 10% tax on Chinese goods…
Impact of Tariffs on the Generic Drug Market
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California (USC, describes how the 10% tax on Chinese goods…
Trump Signs Healthcare Price Transparency Executive Order
Image Credit: Adobe Stock Images/AvectStock.com President Trump recently signed an executive order providing greater healthcare price transparency for patients.1 The order, says the Trump Administration, is expected to help lower healthcare prices, which will ultimately benefit patients and employers when…
Lilly Adds New Zepbound Vial Doses to the Mix
Image Credit: Adobe Stock Images/TadaImages.com Eli Lilly and Company is unveiling its new 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, which will be available for $499 per month using its new Zepbound Self Pay Journey Program.1 The prices of the…
A Side Effect Cascade
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming an increasingly prominent issue in the United States. Polypharmacy has…
Selardsi Launches in the US Market
Image Credit: Adobe Stock Images/Oporty786.com Selarsdi (ustekinumab-aekn) an injection for the treatment of psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, pediatric plaque psoriasis, and pediatric psoriatic arthritis that is also a biosimilar to Stelara (ustekinumab), is officially available in the…
Understanding Polypharmacy
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming an increasingly prominent issue in the United States. Polypharmacy has…
PharmExec’s 20th Annual 2025 Pipeline Report, Patient Journey and the Role of the Pharmacist & more
2025 Pipeline Report: The Edge of Greatness? The biopharmaceutical industry has long been at the forefront of innovation. From the rise of precision medicine, to artificial intelligence technologies accelerating drug development, to the advent of small-molecule drugs, recent revolutions in…
Global Launch Strategies in the Current Political Climate, Pharmacists Help Navigate Vaccine Schedules & more
Global Launch Strategies in the Current Political Climate James Foster, CEO and co-founder of Virax Biolabs, discusses how global launches are being impacted by changing geopolitical conditions. Pharmacists Help Patients Navigate Vaccine Schedules Many patients may struggle to understand the…
Challenges in Developing T Cell Engagers, Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses & more
Challenges in Developing T Cell Engagers Ian Chan, CEO of Abpro, discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering. Abpro’s platform can create novel antibodies at industry-leading speeds, which are then reassembled into custom…
The Biosimilars Landscape Through the Eyes of an Economist
James D. Chambers, PhD, MPharm, MSc James D. Chambers, PhD, MPharm, MSc, is a health economist by trade. After earning his MSc in Health Economics from the University of York and his doctorate in that same focus with Brunel University’s…
The Role of Electronic Labeling in Sustainable Practices
In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences and pharmaceutical sectors. According to Johnson, the adoption of cloud-enabled…
ImmunityBio to Supply Recombinant BCG to Alleviate Tice BCG Shortage
Image Credit: Adobe Stock Images/FreshIdea.com The FDA has approved an expanded access program that will provide an alternative for Tice BCG—a Merck medication that treats various types of bladder cancer—to patients in the United States.1 A rise in global demand…
Enhancing Pharma Supply Chain Transparency and Trust
In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences and pharmaceutical sectors. According to Johnson, the adoption of cloud-enabled…
Trump Reveals Plan to Enact 25% Tariff on Pharmaceuticals
Image Credit: Adobe Stock Images/AndrzejTokarski.com After revealing a plan in which the United States would match the tax rates of what trading partners also charge on imports (as a way to balance the trade scales),1 President Trump recently announced that…
Pharma in the Age of Social Media, Rising Demand for GLP-1 Receptor Agonists Means More Questions & more
Navigating Distrust: Pharma in the Age of Social Media Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim…
Impact of Telehealth Reimbursement Policies on Federally Qualified Health Centers
Image Credit: Adobe Stock Images/Itsaree.com Many would agree that over the past five years or so, telehealth has skyrocketed in popularity, as another way to provide clinical healthcare, increasing access to mental health and managed care.1-4 Nevertheless, this is a…
The Role of Collaborative Supply Chains in Improving Patient Outcomes
In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences and pharmaceutical sectors. According to Johnson, the adoption of cloud-enabled…
BD Voluntary Recalls One Lot of ChloraPrep Clear 1 mL Applicators
The ChloraPrep Clear 1 mL Applicator. Image Credit: BD Becton, Dickinson and Company (BD), a medical technology (MedTech) company that produces and sells medical devices, laboratory equipment, and diagnostic products, is voluntarily recalling one lot of its ChloraPrep Clear 1…
AI’s Role in Shaping the Future of Pharmaceutical Development
In a video interview with Pharma Commerce, James Shehan, chair of the FDA Regulatory practice at Lowenstein Sandler, discusses the potential impact of upcoming tariffs on pharmaceutical supply chains, focusing on Canada, Mexico, and China. He believes that tariffs on…
3PLs and New Voices
Mike Hennessy Jr., President and CEO, MJH Life Sciences 2025 is upon us, officially marking a quarter of a century since Y2K and the midpoint of the decade. There is no doubt that time does quickly fly by, and with…
Pharmaceutical Commerce – February 2025 Issue (PDF)
Pharmaceutical Commerce – February 2025 Issue (PDF) Beyond the GLP-1 Headlines Conference Connect: Navigating the Future of Pharma Trade 3PLs: From Resilience to Sustainability The Prominence of Pharmacy Deserts Breaking Point: How 2025 Will Reshape Patient Support Services M&A in…
PwC Report Identifies Top Trends in Pharma, Counseling About Cannabis Use is Crucial & more
PwC Report Identifies Top Trends in Pharma PwC report identifies transformative trends impacting the pharma market this year and into the future. As Use Becomes More Widespread, Counseling About Cannabis Use Is Crucial The trend toward higher-potency marijuana could pose…
RFK Jr. Confirmed as HHS Secretary, How Pharma Can Effectively Combat Misinformation & more
How Pharma Can Effectively Combat Misinformation/Disinformation In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies pharmaceutical companies can use to combat misinformation on social media. Partnering for Women’s Health: The Pharmacist’s…
Axplora Invests $52.5 Million into GLP-1 Manufacturing Facility
Image Credit: Adobe Stock Images/IrisFocus.com Axplora, a partner to pharma companies and biotechs for complex active pharmaceutical ingredients (APIs), is investing $52.5 million into its Mourenx plant in Southwest France, as it looks to bolster its capabilities in the areas of cardiovascular and metabolic diseases. This specific project will…
How HCPs and Patients Influence the CGT Approval Process
In a video interview with Pharma Commerce, Jenna Dale, direct of client relations at Cencora, shares how pharmaceutical manufacturers are able to handle supply chain disruptions. She explains that while these issues may arise due to political or environmental factors,…
Trump Enacts Reciprocal Tariffs on Trading Partners
Image Credit: Adobe Stock Images/Bernice.com Earlier this afternoon, President Trump revealed a plan in which the United States would match the tax rates of what trading partners also charge on imports, as a way to balance the trade scales, according…